BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7105708)

  • 1. Serum thyroglobulin levels: their use in monitoring thyroid carcinoma.
    Schwartz MA; Blahd WH
    Conn Med; 1982 Apr; 46(4):189. PubMed ID: 7105708
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of serum thyroglobulin in differentiated thyroid cancer. A review and 3 cases].
    Feldt-Rasmussen U; Hansen HS; Rasmusson B
    Ugeskr Laeger; 1983 Apr; 145(15):1132-6. PubMed ID: 6879741
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum thyroglobulin in the follow-up of patients treated for differentiated carcinoma of the thyroid. Evaluation of factors determining its effectiveness].
    García Solís D; Rodríguez Rodríguez JR; Acosta D; Astorga R
    Med Clin (Barc); 1986 May; 86(18):748-52. PubMed ID: 3736171
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum thyroglobulin measurements: clinical utility and technical limitations in the management of patients with differentiated thyroid carcinomas.
    Spencer CA
    Endocr Pract; 2000; 6(6):481-4. PubMed ID: 11155225
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prognostic value of thyroglobulin levels for survival in patients with differentiated carcinoma of the thyroid gland].
    Nĕmec J; Bílek R; Zamrazil V; Chytrý P; Vlcek P
    Cas Lek Cesk; 1997 Dec; 136(23):23-4. PubMed ID: 9476372
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum thyroglobulin in thyroid neoplasms].
    Mimura T; Ishikawa N; Hasegawa M; Manabe Y; Momotani S
    Horumon To Rinsho; 1983 Aug; 31(8):731-5. PubMed ID: 6627707
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictive value of serum thyroglobulin after surgery for thyroid carcinoma.
    Hall FT; Beasley NJ; Eski SJ; Witterick IJ; Walfish PG; Freeman JL
    Laryngoscope; 2003 Jan; 113(1):77-81. PubMed ID: 12514386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum thyroglobulin levels in patients with differentiated thyroid carcinoma.
    Van Herle AJ
    Ann Radiol (Paris); 1977; 20(8):743-5. PubMed ID: 610543
    [No Abstract]   [Full Text] [Related]  

  • 9. [Response of thyroglobulin, anti-thyroglobulin antibodies, TSH, FT4 and total T3 after rhTSH stimulation in differentiated thyroid carcinoma].
    Moreno Ortega E; Vallejo Casas JA; Mena Bares LM; del Real Núñez R; Maza Muret FR; Hidalgo Ramos FJ; Latre Romero JM
    Rev Esp Med Nucl; 2008; 27(4):253-8. PubMed ID: 18682151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum thyroglobulin measurements in differentiated thyroid cancer.
    Girelli ME; De Vido D
    Biomed Pharmacother; 2000 Jul; 54(6):330-3. PubMed ID: 10989968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
    Weightman DR; Mallick UK; Fenwick JD; Perros P
    Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma.
    Sawka AM; Orlov S; Gelberg J; Stork B; Dowar M; Shaytzag M; Tabatabaie V; Freeman JL; Walfish PG
    Head Neck; 2008 Jun; 30(6):693-700. PubMed ID: 18098308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thyroglobulin as a tumor marker].
    Inada M
    Nihon Rinsho; 1980 Dec; 38(12):4647-51. PubMed ID: 7253242
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
    Heemstra KA; Liu YY; Stokkel M; Kievit J; Corssmit E; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambiguous thyroglobulin assay results in the follow-up of differentiated thyroid carcinoma.
    Stockigt JR
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5904-5. PubMed ID: 16207895
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thyroglobulin: usefulness and limits in monitoring patients with thyroid carcinoma].
    Hammami H; Sellem A; Ben Sellem D; Aouni Z; Elabri SB; Mezigh C; Machghoul S; Ben Brahim H
    Tunis Med; 2007 Feb; 85(2):128-30. PubMed ID: 17665659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma.
    Whitley RJ; Ain KB
    Clin Lab Med; 2004 Mar; 24(1):29-47. PubMed ID: 15157556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum thyroglobulin (S-hTG): a tumor marker in patients with differentiated thyroid carcinoma (author's transl)].
    Jänsch A; Heinze HG; Hast B
    Strahlentherapie; 1981 Jun; 157(6):381-92. PubMed ID: 7256806
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyroglobulin and recurrence of thyroid cancer.
    Miwanitkit V
    S Afr J Surg; 2012 Mar; 50(2):52. PubMed ID: 22622106
    [No Abstract]   [Full Text] [Related]  

  • 20. The importance of the thyroglobulin level in the therapy supervision of thyroid carcinoma patients.
    Schneider G; Wünsche A; Kämpfer I; Blottner A; Lobers W
    Radiobiol Radiother (Berl); 1987; 28(5):659-61. PubMed ID: 3441618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.